First Page | Document Content | |
---|---|---|
Date: 2010-01-26 07:06:39Peptide hormones Thyroid Liraglutide Anti-diabetic medication Metformin Medullary thyroid cancer Novo Nordisk Rosiglitazone Sulfonylurea Diabetes management Calcitonin Glimepiride | Victoza (liraglutide [rDNA origin] injectionAdd to Reading ListSource URL: www.accessdata.fda.govDownload Document from Source WebsiteFile Size: 273,22 KBShare Document on Facebook |
EMDAC Background document Victoza (liraglutide) - LEADER FDA Briefing Document Endocrinologic and Metabolic Drugs Advisory Committee Meeting (EMDAC)DocID: 1ts1R - View Document | |
Victoza (liraglutide [rDNA origin] injectionDocID: 1nE7h - View Document | |
Access to medicines - time for a progressive model Richard Bergström, EFPIA Director General 1DocID: 1aTpx - View Document | |
PDF DocumentDocID: 16ope - View Document | |
12933_2015_206_Article 1..11DocID: 15UUB - View Document |